Test Bank for Applied Pharmacology for the Dental Hygienist 8th Edition by Haveles

Test Bank for Applied Pharmacology for the Dental Hygienist 8th Edition by Haveles

Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and Prescription Writing

Haveles: Applied Pharmacology for the Dental Hygienist, 8th Edition

MULTIPLE CHOICE

1.         Knowledge of pharmacology aids the dental professional in

a.        obtaining a patient’s health history.

b.        administering drugs in the office.

c.        handling emergency situations.

d.        selection of a nonprescription medication.

e.        All of the above

ANS: E

All of the choices are true. Because many of our patients are being treated with drugs, knowledge of pharmacology helps in understanding and interpreting patients’ responses to health history questions. Knowledge of the therapeutic and adverse effects of medications obviously helps in their proper administration in the office. Emergency situations may be caused by drugs or treated by drugs; thus, knowledge of pharmacology is of great help, especially because a rapid response is sometimes required. A clear understanding of the concepts of drug action, drug handling by the body, and drug interactions will allow the dental practitioner to make proper judgments and grasp the concepts relevant to new drug therapies on the market.

DIF: Application REF: Role of the Dental Hygienist | p. 2 & 3 OBJ: 1 TOP: NBDHE, 6.0. Pharmacology

2.         Which of the following statements is true regarding planning appointments?

a.        Whether or not patients are taking medication for systemic diseases is of little consequence in the dental office.

b.        Asthmatic patients should have dental appointments in the morning.

c.        Diabetic patients usually have fewer problems with a morning appointment compared with afternoon appointments.

d.        Both B and C are true.

ANS: D

Asthmatic patients who experience dental anxiety should schedule their appointments when they are not rushed or under pressure early in the morning. Diabetic patients usually have relatively fewer problems with a morning appointment. Patients taking medication for systemic diseases may require special handling in the dental office.

               DIF: Comprehension           

REF: Role of the Dental Hygienist (Appointment Scheduling) | p. 3 OBJ: 1 TOP: NBDHE, 6.0. Pharmacology

3.         Nutritional or herbal supplements

a.        carry the U.S. Food and Drug Administration (FDA) approval for disease states. b.      are not drugs.

c.        can cause adverse effects.

d.        will not interact with other drugs the patient may be taking.

ANS: C

Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of nutritional or herbal supplements do not carry FDA approval for treating disease states. These supplements are drugs and can cause adverse effects and interact with different drugs.

               DIF: Comprehension           

REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements) | p. 3

               OBJ: 1                     TOP: NBDHE, 6.0. Pharmacology

4.         Which type of drug name usually begins with a lowercase letter?

a.        Brand name

b.        Code name

c.        Generic name

d.        Trade name

ANS: C

Before any drug is marketed, it is given a generic name that becomes the “official” name of the drug. Each drug is assigned only one generic name selected by the U.S. Adopted Name Council, and the name is not capitalized. The brand name is equivalent to the trade name and is capitalized. Although the brand name is technically the name of the company marketing the product, this term is often used interchangeably with the trade name. The code name is the initial term used within a pharmaceutical company to refer to a drug while it is undergoing investigation and is often a combination of capital letters and numbers, the letters representing an abbreviation of the company name.

               DIF: Comprehension                                REF: Drug Names | p. 4

               OBJ: 3                     TOP: NBDHE, 6.0. Pharmacology

5.         A drug’s generic name is selected by the

a.        pharmaceutical company manufacturing it.

b.        Food and Drug Administration (FDA).

c.        U.S. Adopted Name Council.

d.        Federal Patent Office.

ANS: C

Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted Name Council. The generic name is not selected by the FDA or the Federal Patent Office. The pharmaceutical company manufacturing the drug clearly has an influence on the generic name given its drug, but the final decision is not the company’s.

                DIF: Recall              REF: Drug Names | p. 4                             OBJ: 3

TOP: NBDHE, 6.0. Pharmacology

6.         Which of the following is true concerning generic and trade names of drugs?

a.        A drug may only have one generic name and one trade name.

b.        A drug may only have one generic name, but it may have several trade names.

c.        A drug may have several generic names, but it may only have one trade name.

d.        A drug may have several generic names and several trade names.

ANS: B

Each drug has only one generic name but may have several trade names. For each drug, there is only one generic name. It is not capitalized, and it becomes the “official” name of the drug. The pharmaceutical company discovering the drug gives the drug a trade name. The trade name is protected by the Federal Patent Law for 20 years from the earliest claimed filing date, plus patent term extensions. Although the brand name is technically the name of the company marketing the product, it is often used interchangeably with the trade name.

               DIF: Comprehension                                REF: Drug Names | p. 4

               OBJ: 3                     TOP: NBDHE, 6.0. Pharmacology

7.         Two drugs that are found to be chemically equivalent, but not biologically equivalent or therapeutically equivalent are said to differ in

a.        potency.

b.        efficacy.

c.        bioavailability.

d.        therapeutic index.

ANS: C

A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. These products are said to differ in their bioavailability. The potency of a drug is a function of the amount of drug required to produce an effect. The efficacy is the maximum intensity of effect or response that can be produced by a drug. The therapeutic index is the ratio of the lethal dose for 50% of the experimental animals divided by the effective dose for 50% of the experimental animals. If the value of the therapeutic index is small, toxicity is more likely.

DIF: Recall        REF: Drug Substitution | p. 5   OBJ: 4 TOP: NBDHE, 6.0. Pharmacology

8.         How many years must pass after a drug patent expires before other drug companies can market the same compound as a generic drug?

a.        20 years

b.        17 years

c.        7 years

d.        0 years

ANS: D

Once a drug patent expires, competing companies may immediately market the same compound in generic form. After 17 years, the patent of the original drug expires, and other companies can market the same compound under a generic name.

               DIF: Application     REF: Drug Names (Drug Substitution) | p. 5

               OBJ: 4                     TOP: NBDHE, 6.0. Pharmacology

9.         Two drug formulations that produce similar concentrations in the blood and tissues after drug administration are termed _____ equivalent.

a.        chemically

b.        biologically

c.        therapeutically

ANS: B

Biologic equivalence refers to identical pharmacokinetic parameters of two drug formulations (bioequivalence, for short). Chemical equivalence indicates that two formulations of a drug meet the chemical and physical standards established by the regulatory agencies. Therapeutic equivalence means that two formulations produce the same therapeutic effects over the same duration.

               DIF: Application     REF: Drug Names (Drug Substitution) | p. 5

               OBJ: 4                     TOP: NBDHE, 6.0. Pharmacology

10.     The federal body that determines whether a drug is considered a controlled substance and to which schedule it belongs is the a.         Food and Drug Administration (FDA).

b.        Federal Trade Commission (FTC).

c.        Drug Enforcement Administration (DEA).

d.        U.S. Pharmacopeia (USP).

ANS: C

The DEA regulates the manufacture and distribution of substances with abuse potential. Hence prescriber DEA numbers must appear on prescriptions for controlled substances. The FDA does not have any special powers in regard to drugs of abuse. The FTC regulates commerce and advertising claims of foods, over-the-counter (OTC) products, and cosmetics. The USP regulates the uniformity and purity of drugs.

               DIF: Comprehension           

REF: Federal Regulations and Regulatory Agencies (Drug Enforcement Administration) | p. 5

               OBJ: 5                     TOP: NBDHE, 6.0. Pharmacology